# Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis

> **NCT04501211** · PHASE2 · WITHDRAWN · sponsor: **Indiana University**

## Conditions studied

- Gastroparesis

## Interventions

- **DRUG:** Granisetron

## Key facts

- **NCT ID:** NCT04501211
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Abandoned due to limited resources
- **Last updated:** 2022-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04501211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04501211, "Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04501211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*